FDA Inspection 1219094 — Otsuka Pharmaceutical Development & Commercialization, Inc
The FDA completed an inspection of Otsuka Pharmaceutical Development & Commercialization, Inc on Sep 7, 2023 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 7, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rockville, MD (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)